From October 1, 2022 to December 31, 2022, the company has repurchased 5,409,000 shares, representing 0.49% for CNY 45.67 million. With this, the company has completed the repurchase of 33,001,600 shares, representing 2.97% for CNY 289.98 million under the buyback announced on April 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.21 CNY | -0.14% |
|
-3.74% | -33.05% |
06-18 | Jinyu Bio-Technology's Unit Gets Nod to Produce Triple Cat Vaccine | MT |
05-28 | China Issues Temporary Approval for Jinyu's Inactivated Bovine Nodular Dermatosis Vaccine | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.05% | 1.11B | |
-12.16% | 79.1B | |
-3.15% | 7.13B | |
+21.25% | 3.58B | |
-9.18% | 2.93B | |
+16.05% | 1.69B | |
-8.50% | 1.19B | |
-36.85% | 1.05B | |
-3.22% | 884M | |
-16.90% | 867M |
- Stock Market
- Equities
- 600201 Stock
- News Jinyu Bio-technology Co., Ltd.
- Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.